Objective To empirically compare the measurement properties of the DEMQOL-U and DEMQOL-Proxy-U instruments to the EQ-5D-5L and its proxy version (CEQ-5D-5L) in a population of frail older people living in residential aged care in the post-hospitalisation period following a hip fracture. Methods A battery of instruments to measure health-related quality of life (HRQoL), cognition, and clinical indicators of depression, pain and functioning were administered at baseline and repeated at 4 weeks' followup. Descriptive summary statistics were produced and psychometric analyses were conducted to assess the levels of agreement, convergent validity and known group validity between clinical indicators and HRQoL measures. Results There was a large divergence in mean (SD) utility scores at baseline for the EQ-5D-5L and DEMQOL-U [EQ-5D-5L mean 0.21 (0.19); DEMQOL-U mean 0.79 (0.14)]. At 4 weeks' follow-up, there was a marked improvement in EQ-5D-5L scores whereas DEMQOL-U scores had deteriorated. [EQ-5D-5L mean 0.45 (0.38); DEMQOL-U mean 0.58 (0.38)]. The EQ-5D and CEQ-5D-5L were more responsive to the physical recovery trajectory experienced by frail older people following surgery to repair a fractured hip, whereas the DEMQOL-U and DEMQOL-Proxy-U appeared more responsive to the changes in delirium and dementia symptoms often experienced by frail older people in this period. Conclusions This study presents important insights into the HRQoL of a relatively under-researched population of post-hospitalisation frail older people in residential care. Further research should investigate the implications for economic evaluation of self-complete versus proxy assessment of HRQoL and the choice of preference-based instrument for the measurement and valuation of HRQoL in older people exhibiting cognitive decline, dementia and other co-morbidities. 
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Key Points for Decision Makers
In contrast to the proliferation of studies reporting upon an assessment of the quality of life of older people in community-based setting there is a paucity of evidence relating to the health-related quality of life of older people living in residential care.
This paper provides an empirical assessment of the measurement properties of the newly developed DEMQOL-U and DEMQOL-Proxy-U instruments compared with the EQ-5D-5L and its proxy version in a population of frail older people residing in residential aged care in the post-acute period following a hip fracture.
The findings highlight the central importance of selfcomplete versus proxy assessment and the choice of preference-based instrument for the measurement and valuation of health-related quality of life in older people exhibiting cognitive decline, dementia and other co-morbidities.
Introduction
A hip fracture represents a sentinel event in the life of an older person with estimates indicating that 25-35% will die within a year of incurring a fractured hip [1] whilst only 40% will rediscover the level of mobility they enjoyed prior to the fracture [2] . In Australia, it has been estimated that approximately 30% of all hip fractures occur in residential aged-care facilities [3] . In contrast to the proliferation of studies reporting upon the health-related quality of life (HRQoL) of older people recovering from hip fracture in community-based settings, there is a lack of evidence relating to the HRQoL of older people recovering from hip fracture living in residential care. Those studies which have been conducted in this setting have tended to focus more generically on the measurement of quality of life of residents and have typically reported quality of life to be very poor in this population [4] [5] [6] . The DEMQOL and DEMQOL-Proxy were developed as condition-specific instruments to capture the measurement of HRQoL of individuals with cognitive decline and dementia where the DEMQOL was designed to be selfcompleted by the individual and the DEMQOL-Proxy was designed to be completed by a suitable proxy, e.g. close family member or a carer [7, 8] . In their original form both the DEMQOL and the DEMQOL-Proxy are not suitable for use in economic evaluation as they provide summary scores that are not preference based. However, the recent development of the DEMQOL-U and DEMQOL-Proxy-U using general population preference values has facilitated the application of these measures in economic evaluations [9, 10] .
The EQ-5D represents the World's most widely used preference-based measure of HRQoL and the instrument is well known for its reliability, responsiveness and validity [11] . The acceptability and feasibility of the EQ-5D for administration with individuals exhibiting mild-to-moderate cognitive impairment and living in residential aged care and has been demonstrated in several published studies internationally [12] [13] [14] [15] . For individuals who are unable to self-complete the EQ-5D due to more severe levels of cognitive impairment, a proxy version is available (CEQ-5D). A recent study analysed the psychometric properties of the EQ-5D rated by proxy and demonstrated its validity and reliability in individuals living in residential care with different stages of dementia [15] . The study authors concluded that proxy assessment may improve the feasibility of the EQ-5D for individuals at advanced stages of dementia who are unable to self-complete the instrument.
The high prevalence of hip fractures occurring in residential aged-care facilities highlights the importance of providing cost-effective post-hospitalisation treatment and care pathways [6] . Within economic evaluation, benefits are most often captured by quality-adjusted life years (QALYs) through the administration of preference-based measures such as the DEMQOL-U, DEMQOL-Proxy-U and EQ-5D [11] . However, selecting the most appropriate instrument/s for measuring and valuing HRQoL in frail older people recovering from hip fracture and living in residential care is not straightforward. Hip fracture patients returning to residential care from hospital typically experience differential care and rehabilitation treatment pathways that may impact upon their physical recovery trajectory [2] . They often also experience delirium and consequently are at greater risk of experiencing accelerations in cognitive decline and dementia [2, 6] . Hence potentially there is a role for both the condition-specific DEMQOL-U and DEMQOL-Proxy-U and generic EQ-5D instruments in this context. Although these instruments have all been designed to generate QALYs for economic evaluation (on an equivalent 0 = dead, 1 = full health QALY scale), in practice they have a differential focus in terms of both the nature and content of their descriptive systems and the ranges associated with their relevant scoring systems. Currently there is a paucity of empirical evidence to guide the selection of the most appropriate outcome measure/s for application in this population and setting [6, 11] . Empirical evidence to compare the measurement properties of potentially relevant instruments is important as it may have important implications for the results of economic evaluation studies to assess the cost effectiveness of rehabilitation and treatment pathways for older people recovering from a hip fracture living in residential care.
The main aim of this study was to conduct an empirical assessment of the measurement properties of the newly developed DEMQOL-U and DEMQOL-Proxy-U instruments to the EQ-5D-5L and its proxy version in a population of frail older people residing in residential aged care in the post-hospitalisation period of recovery (0-4 weeks) following surgery to repair a hip fracture. It was hypothesized a priori that although the DEMQOL-U, DEMQOLProxy-U and EQ-5D-5L instruments were all designed to measure the same concept of utility on an equivalent QALY scale (where zero represents the state dead and one represents the state of full health), the utilities associated with each of these instruments and the magnitude of change over time in utilities may differ. In particular it was hypothesized that the EQ-5D would be more responsive to the physical recovery trajectories experienced by frail older people recovering from a hip fracture, whereas it was hypothesized that the DEMQOL-U and DEMQOL-Proxy-U instruments may be more responsive to the symptoms of dementia often experienced by frail older people living in residential care in the period following a hip fracture.
Methods

Study Population
The data utilised for this study emanates from a randomised controlled trial to investigate the clinical and cost effectiveness of a multidisciplinary rehabilitation service to hip fracture patients living in residential aged care [6] . Recruitment for the randomised controlled trial was from acute orthopaedic wards of three hospitals in South Australia (including Flinders Medical Centre, Flinders Private Hospital and Royal Adelaide Hospital) where participants underwent their surgery following hip fracture. Individuals with an X-ray-confirmed hip fracture managed surgically, aged C70 years, a permanent nursing home resident and who were mobile prior to fracture were eligible for inclusion. Individuals requiring terminal palliative care were excluded. In total 240 older adults, who lived in residential aged care and were ambulatory prior to their fracture were randomised. Participants were randomly allocated to receive a multidisciplinary rehabilitation intervention or usual care involving no post-acute multidisciplinary rehabilitation intervention. The intervention comprised an ambulatory geriatric rehabilitation programme (including review from geriatrician, and intervention from ambulatory rehabilitation team in the nursing home) of 4 weeks' duration.
Measures
A battery of instruments to measure quality of life, cognition, and clinical indicators of depression, pain and functioning were administered at baseline and repeated at 4 weeks' follow-up with individuals living in residential care and recovering from surgery to repair a fractured hip.
In accordance with the recommendations produced by the instrument developers, both the DEMQOL-U and DEMQOL-Proxy-U were administered in individuals with mild-to-moderate dementia, whereas for individuals with severe dementia, only the DEMQOL-Proxy was administered [8] . For proxy assessment, family carers were utilised wherever possible. For a small number of cases where a family carer was unavailable, proxy assessment was undertaken by a residential care staff member involved in the day-to-day care of the individual. The DEMQOL-U classification system comprises five dimensions (positive emotion, memory, relationships, negative emotion and loneliness with four levels of increasing impairment associated with each dimension. The DEMQOL-Proxy-U classification system comprises four dimensions (positive emotion, memory, appearance and negative emotion) with four levels of increasing impairment associated with each dimension. The respective scoring algorithms pertaining to the DEMQOL-U and DEMQOL-Proxy-U classification systems were derived using the time trade-off elicitation technique in a UK general population sample. The resulting utility scores lie on the zero to one quality-adjusted life years (QALY) scale where zero represents the state dead and one represents the state of full health. The utility scores for the DEMQOL-U range from 0.243 to 0.986 and the DEMQOL-Proxy-U from 0.363 to 0.937 [9, 10] .
The EQ-5D is a commonly used preference-based measure of health status designed for completion by patients and/or members of the general population; however, it can also be completed by a proxy (CEQ-5D). The EQ-5D-5L contains five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) with five levels of increasing impairment associated with each dimension. The instrument was recently developed to improve sensitivity and reduce ceiling effects relative to the original 3-level version [16] . Although no guidance currently exists from the instrument developers in relation to self-complete versus proxy administration of the EQ-5D in individuals with cognitive impairment and dementia, evidence from a recent study indicates that people with mild-to-moderate dementia were able to rate their own HRQoL using the EQ-5D, and proxy ratings were found to be consistently different from individual ratings [17] . For the purposes of the randomised controlled trial from which this study emanates, clinical judgement was used to reflect upon the individual's ability to understand and tolerate the task. Self-completion of the EQ-5D-5L was encouraged wherever possible on the basis that the individual is normally viewed as the best judge of their own HRQoL [11] . When engagement with the task was reduced to such a level that the clinician viewed it as unreasonable to commence or continue, then proxy assessment via a family member (or for a small number of cases a staff member in the absence of a family carer) was utilised. A scoring algorithm for the EQ-5D-5L is available based upon the time trade-off and discrete choice experiment approaches with a UK general population sample. The resulting utility scores range from -0.281 to 1 (where states with a score less than zero are considered worse than being dead) [18] .
Cognitive functioning was assessed by the Mini-Mental State Examination (MMSE), a routinely administered brief instrument for the measurement of global cognitive function [19] . The MMSE is the most commonly used test for assessing problems with memory or other mental disabilities, internationally. It is routinely used by clinicians to help diagnose dementia and to help assess its progression and severity [20] . MMSE scores below 10 are indicative of severe dementia, scores between 10 and 20 suggests moderate dementia and finally scores greater than 20 suggest mild dementia to non-existent cognitive impairment [21] . The Cornell Scale for Depression in Dementia (CSDD) is a 19-item instrument completed by clinical assessment that screens for signs of depression specifically among dementia patients [22, 23] . Scores [11 indicate probable depression while scores [18 indicate definite depression.
An individual's functional ability or independence was measured by the Modified Barthel Index (MBI) [24] . The MBI is a 10-item instrument that produces a score between 1 and 100 with a score of 0-20 indicating total dependence, 21-60 severe dependence, 61-90 moderate dependence, 91-99 slight dependence, and a score of 100 indicates that the individual is fully independent in basic daily activities such as showering, dressing and mobility. Pain levels were assessed using the Pain Assessment in Advanced Dementia Scale (PainAd) [25] , an observational instrument designed for administration by a clinician to measure levels of pain in patients with advanced dementia. The instrument produces scores between 0 and 10 with 0 being no pain and 10 indicating severe pain.
Data Analysis
Descriptive Analysis
Descriptive summary statistics were produced initially to provide an overview of the study population in terms of their socio-demographic characteristics and clinical indicators of depression, pain and functioning at baseline. Summary statistics of the quality of life measures of interest, the DEMQOL-U and DEMQOL-Proxy-U and the EQ-5D-5L and CEQ-5D-5L, were generated to show how individuals had responded to these instruments at each time point. The Wilcoxon signed rank test was used to calculate p values and effect size for changes in utility between baseline and week 4 for each of the instruments. According to Cohen criteria an effect size of 0.1 indicates a small effect, 0.3 indicates a medium effect and 0.5 indicates a large effect [26] .
Agreement
Bland-Altman plots were created to assess the levels of agreement between the different measures of quality of life. Bland-Altman plots were generated to explore agreement between DEMQOL-U and EQ-5D-5L, and DEMQOL-Proxy-U and CEQ-5D-5L both at baseline and at the week 4 follow-up period to assess the extent to which similar responses were given to each instrument. As the health states were reported either by the individuals themselves or their carer the patient's 'real' health state is an unknown. Therefore, the x axis of the Bland-Altman plots uses the average of the utility values derived from the two instruments in question. The y axis consists of the difference between the two utility scores. For example, for the Bland-Altman plot assessing agreement between DEMQOL-U and EQ-5D-5L, x = (DEMQOL-U score ? EQ-5D-5L score)/2 and y = DEMQOL-U score -EQ-5D-5L score.
Convergent Validity
The association between DEMQOL-U, EQ-5D-5L and their respective proxy versions, cognition, and clinical indicators of depression, pain and functioning was explored to assess the degree of convergent validity. This involved determining whether there was a strong correlation between the utility scores derived from the DEMQOL-U and EQ-5D-5L (and proxy versions) and scores relating to cognition, clinical indicators of depression, pain and functioning (MMSE, CSDD, MBI and PainAd) using Spearman correlation coefficients. Correlations greater than 0.7 were considered strong and correlations between 0.4 and 0.7 were considered moderate [27] .
Known-Group Validity
Recommended threshold levels for severity categorisations in the clinical indicators of depression, pain and functioning were utilised to facilitate an assessment of knowngroup validity. The Kruskal-Wallis test was used to calculate p values when testing for differences across known groups. It was expected that those with higher levels of pain, higher levels of depression and lower levels of functioning would have a lower quality of life and therefore lower utility values for the DEMQOL-U and EQ-5D-5L. In relation to cognition, the expected direction of the relationship between the severity categorisations of cognition (as defined by the MMSE) and quality of life was less clear. There is some prior evidence to indicate that disease stage progression (dementia severity) is associated with declining quality of life [28, 29] . However, cognitive deterioration has not been found to be consistently associated with quality of life. Prior evidence indicates that there is no clear relationship between the severity of cognition and quality of life [29, 30] .
Results
Sample Characteristics and Descriptive Statistics
A total of 354 individuals were approached to be included in the study of whom N = 240 (68%) were eligible and consented to participate. The socio-demographic characteristics of the study sample are presented in Table 1 . Summary statistics for the EQ-5D, CEQ-5D, DEMQOL-U and DEMQOL-Proxy-U across the study period for the total sample and for the sub-sample of individuals who completed the same version of each instrument at both time points are presented in Table 2 . For the total sample, the mean utility scores at baseline for the EQ-5D-5L and DEMQOL-U were 0.21 and 0.79, respectively. In agreement with our prior hypotheses, the respective utilities and the direction of the change in utilities from baseline to week 4 differed for each instrument. As expected, the EQ-5D-5L improved in general at the week 4 follow-up with a mean score of 0.45, whereas the mean score for the DEMQOL-U at the week 4 follow-up had fallen to 0.58. Regarding the proxy versions of the instruments, the CEQ-5D-5L and the DEMQOL-Proxy-U had mean scores of 0.23 and 0.63, respectively at baseline. The proxy instruments also followed the same pattern as their respective patient-completed versions in that the mean score for the CEQ-5D-5L increased at the week 4 follow-up to 0.38 while the DEMQOL-Proxy-U mean score fell to 0.57. When complete case data only were analysed a similar pattern is evident for the EQ-5D-5L with a mean score of 0.25 at baseline and an improvement in general at the week 4 follow-up with a mean score of 0.58. For the DEMQOL-U there was a slight reduction in scores from baseline (0.81) to week 4 (0.80), whilst for the DEMQOL-Proxy-U there was a slight improvement in scores from baseline (0.64) to week 4 (0.66). Figure 1 presents Bland-Altman plots showing the level of agreement between the individual self-reported utility measures (EQ-5D-5L and DEMQOL-U) and their respective proxy versions (CEQ-5D-5L and DEMQOL-Proxy-U) Fig. 1 Bland Altman plot assessing agreement between DEMQOL-U and EQ-5D, and CEQ-5D and DEMQOL-Proxy-U utility values at baseline at baseline. It is evident that there is little agreement between the two measures at baseline, with most responses clustering around the mean difference of 0.551. This finding indicates that individuals tended to exhibit systematically higher utility scores on the DEMQOL-U. This pattern does change at week 4 follow-up (presented in Fig. 2 ) as responses cluster around the y = 0 line at higher levels of utility suggesting there is better agreement at the upper end of the utility scale. However, it is evident that there is still disagreement at lower utility levels with the DEMQOL-U indicating higher scores on average.
Agreement
The proxy-reported measures indicate disagreement at baseline between the two measures at lower utility levels. As utility levels increase the responses move closer to y = 0; however, they mainly cluster around the mean difference of 0.403 indicating that responses to DEMQOL-Proxy-U are higher than those of the CEQ-5D-5L. At week 4 and in common with the patient-reported measures, there is more agreement with a high proportion of responses around the y = 0 line particularly at higher utility levels. At lower utility levels, there is still disagreement and the cluster around the mean Fig. 2 Agreement between DEMQOL-U and EQ-5D, and CEQ-5D and DEMQOL-Proxy-U utility values at week 4 difference remains although the mean difference decreased slightly to 0.279.
Convergent Validity
Spearman correlations between the utility-based health measures and the non-utility-based health measures are presented in Table 3 . At baseline, of the individual selfreported measures, only the EQ-5D-5L is significantly associated with MMSE score. However, the correlation is below 0.4 and therefore cannot be classified as moderate or strong. The EQ-5D-5L and DEMQOL-U were significantly associated with CSDD, MBI and PainAd in the expected direction (utility increases as CSDD or PainAd decreases and utility increases as MBI increases). Most of the correlations were moderate except for the relationships between (1) the CSDD and EQ-5D-5L, and (2) the MBI and DEMQOL-U, which indicated low correlations. In relation to the proxy-reported instruments, the DEMQOLProxy-U was significantly associated with all the nonutility measures and in the expected direction. The CEQ-5D-5L and DEMQOL-Proxy were both found to be significantly associated with the CSDD and the PainAd but only their correlations with CSDD could be classified within the moderate range. At week 4, although the correlations remained in the expected directions, fewer of the relationships were identified as statistically significant. In general, the proxy-reported instruments performed better than their self-complete counterparts in terms of their associations with the non-utility-based health measures. However, in contrast to baseline, at week 4 none of the correlations were above 0.4, indicating relatively poor associations in general.
Known-Group Validity
Tables 4 and 5 present the mean patient and carer utility scores categorised into severity groups of clinical indicators and cognition at baseline and 4 weeks, respectively. For depression, measured by the CSDD, all the instruments behave as one would expect at both time-points with utilities decreasing as the severity of depression increases. The effect sizes are all below 0.3 indicating a small-to-moderate effect. For self-care, as measured by the MBI, all individuals were classified into the two most severe groups at baseline (severe dependence or total dependence). However, at week 4 there was more of a range with individuals classified from slight to total dependence. The two self-reported measures (EQ-5D and DEMQOL-U) behaved as expected with utilities decreasing as dependency levels increased. For the CEQ-5D-5L and the DEMQOL-Proxy however, there was less of a clear pattern, although the small numbers in some categories may have affected these comparisons. Except for the move from slight to moderate dependence, which indicated a medium effect size (0.43) for the EQ-5D-5L, all other effect sizes were small to moderate. Finally, all the utility measures behaved as expected in relation to the PainAd instrument at baseline, with utilities falling as reported pain levels increased. However, at 4 weeks the pattern was less clear, with the CEQ-5D-5L in particular appearing to be relatively insensitive to pain levels as reported by the PainAd instrument at 4 weeks. The effect sizes are all below 0.3 indicating a small-to-moderate effect overall.
For cognitive impairment, as measured by the MMSE, at baseline it can be seen that the lower utilities for the EQ-5D-5L and DEMQOL-Proxy-U are associated with more severe levels of cognitive impairment. The DEMQOL-U follows a similar pattern in that utility decreases as cognitive impairment increases from mild to moderate; however, utility increases again at levels of severe cognitive impairment. At week 4, the pattern of the relationships is less clear overall, with more of a differentiation evident between utilities and the degree of cognitive impairment for the DEMQOL-U and DEMQOL-Proxy-U relative to the EQ-5D-5L and CEQ-5D-5L. As with the clinical indicators, the effect sizes are all below 0.3 indicating a small-to-moderate effect overall.
Discussion
This study represents the first study internationally to empirically compare the measurement properties of the DEMQOL-U and DEMQOL-Proxy-U to the EQ-5D-5L and CEQ-5D-5L in a post-hospitalisation population of older people living in residential care. Evidence is presented regarding the agreement, validity and responsiveness of the DEMQOL-U and DEMQOL-Proxy-U dementia-specific preference-based HRQoL measurement system and the EQ-5D generic preference-based measure in comparison with external indicators of dementia-related health status. Overall, we found little evidence of agreement between the DEMQOL-U and EQ-5D, and CEQ-5D and DEMQOL-Proxy-U. This finding may be attributable to the dementia condition-specific focus of the DEMQOL in contrast to the EQ-5D, which has particular focus on the physical functioning dimensions (such as mobility, self-care and the ability to perform usual activities) that are severely impacted in the immediate period following a hip fracture.
To our knowledge only one other study has empirically compared the DEMQOL-U and DEMQOL-Proxy-U to the EQ-5D-5L and CEQ-5D-5L [10] . In comparison with our study population, the study by Mulhern and colleagues was undertaken in a sample with a higher prevalence of individuals (88%) with mild-to-moderate dementia, with only 12% exhibiting severe dementia (MMSE score \10). In addition to higher levels of cognitive impairment, on average, the individuals in our study sample were also physically frail and due to the nature of their condition almost all were classified as totally dependent at baseline. The differences in study populations are reflected in baseline EQ-5D scores with a mean EQ-5D score of 0.21 in this study relative to a mean EQ-5D score of 0.68 in the UK study population. As expected, given the differential nature of the respective study populations in terms of the levels of cognitive impairment, the DEMQOL-U and DEMQOL-Proxy-U scores reported in this study were also lower, on average, than those reported by Mulhern and colleagues at both time points (baseline and week 4). However, despite differences in populations and study settings, there were some notable similarities between the findings of the study by Mulhern and colleagues and the study reported here. In terms of the agreement found between the DEMQOL-U and EQ-5D, and CEQ-5D and DEMQOL-Proxy-U, a higher level of agreement was found at the upper end of the utility scale with most of the disagreement occurred at the more severe end of the utility scale.
The evidence from this study in relation to the convergent validity and known group validity of the instruments with clinical measures of depression, functioning and pain indicates that all the instruments behaved as would be expected with utilities falling in general as clinical severity classifications increased. In relation to cognition, the expected direction of the relationship between the severity categorisations (as defined by the MMSE) and quality of life was less clear. Other studies have also reported mixed findings indicating that there is no clear relationship between the severity of cognition and quality of life [30, 31] . It has been hypothesized that the relationship between cognition and quality of life is potentially multifaceted and complex and the impact of worsening cognition on quality of life may be potentially offset by a combination of social, psychological and environmental factors [31] . Examination of the distribution of utility values indicated that the DEMQOL-U and its proxy version, systematically produced higher utility values relative to the EQ-5D-5L and CEQ-5D-5L. This finding may be due to differences in the classification systems, which are sensitive to different dimensions of HRQoL and due to large differences in the possible utility scale range. The EQ-5D-5L utility scores range from -0.281 to 1 whilst the utility scores range from 0.243 to 0.986 for DEMQOL-U and 0.363 to 0.937 for DEMQOL-Proxy-U.
It is evident that both the EQ-5D-5L and CEQ-5D-5L utility scores demonstrated significant positive improvements between baseline and week 4. In contrast, smaller changes were evident for DEMQOL-U or the DEMQOL-Proxy-U during this time-period and often in a negative direction. In accordance with our prior hypotheses, this study therefore indicates that the EQ-5D was more responsive to the physical recovery trajectory experienced by frail older people recovering from surgery to repair a fractured hip, whereas it is likely that the DEMQOL-U and DEMQOL-Proxy-U instruments were more responsive to the changes in delirium cognitive functioning and dementia symptoms often experienced by frail older people in the immediate period following a hip fracture [2, 6] . Clearly, the findings from this study demonstrate that the choice of instrument for the calculation of QALYs may have a significant impact upon any assessment of the cost effectiveness of rehabilitation and treatment pathways for older people recovering from a hip fracture living in residential care. Whilst the EQ-5D appeared more responsive than the DEMQOL-U and DEMQOL-Proxy-U instruments to the physical recovery trajectory experienced by older people in this specific context, the extent to which these findings are more generalizable to populations of older people living in residential care is not clear. Further research is needed to compare the performance of the EQ-5D with the DEM-QOL-U and DEMQOL-Proxy-U instruments and other dementia condition-specific measures and to assess change over time in populations of older people living in residential care with cognitive decline but with higher levels of physical functioning than the sample included in this study. This study also raises important questions about the level of cognitive ability beyond which an individual is unable to provide a reliable self-assessment of their own HRQoL, and proxy assessment should therefore be sought. The limitations of this study include the relatively short period of follow-up (4 weeks) and the lack of dyad assessments of patient and proxy HRQoL to facilitate a detailed investigation of inter-rater agreement. Previous studies to investigate the agreement in utility values between self-and proxy-rated HRQoL for people with dementia have indicated only a poor-to-moderate level of agreement overall, with proxy assessors tending to report lower HRQoL than individuals themselves [17, 32, 33] . The choice of proxy assessor (e.g. family member, residential care staff member, clinician) has also previously been found to be associated with discrepancies in assessment of HRQoL using the EQ-5D [17, 32, 33] . These findings may also have potentially important implications for the results of economic evaluation studies.
Conclusions
This study presents insights into the HRQoL of a relatively highly under-researched population of post-hospitalisation frail older people in residential care, previously evocatively described as members of the 'lost tribe' [34] . The findings highlight important questions relating to the choice of the most appropriate preference-based instrument in post-hospitalisation populations of frail older people with cognitive decline, dementia and other co-morbidities living in residential care, and the decision as to from whose perspective HRQoL is assessed. Further research should be conducted to explore the implications of these choices for the results of economic evaluation studies conducted in this setting.
